🇺🇸 continuous intravenous sufentanil 0.02μg•kg-1•h-1 infusion in United States

continuous intravenous sufentanil 0.02μg•kg-1•h-1 infusion (continuous intravenous sufentanil 0.02μg•kg-1•h-1 infusion) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

continuous intravenous sufentanil 0.02μg•kg-1•h-1 infusion in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is continuous intravenous sufentanil 0.02μg•kg-1•h-1 infusion approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for continuous intravenous sufentanil 0.02μg•kg-1•h-1 infusion in United States?

Jin Ni is the originator. The local marketing authorisation holder may differ — check the official source linked above.